Certain Klebsiella sp. antigens cross-react with an HLA-B27-associated cell surface marker on the cells of about 80% of patients with B27-positive ankylosing spondylitis (AS) and 60% of those with Reiter's syndrome or asymmetrical peripheral arthritis (9, 21) . These observations imply that certain Klebsiella sp., or antigenically related organisms, play an important role in the pathogenesis of these B27-associated seronegative arthropathies (12) . However, the finding that HLA-B27-associated reactive arthritis follows infections with enteric organisms such as Shigella sp., Salmonella sp., and Yersinia sp. (1, 10, 19) raises the possibility that a range of enteric bacteria may share determinants with the B27-associated structure on the tissues of patients with AS, reactive arthritis, and other types of B27-positive seronegative arthropathies. Previous surveys of randomly selected cultures of Klebsiella sp. indicated that about 8% of Klebsiella sp. isolates cross-react with B27+AS+ lymphocytes (13, 14) . We have now broadened this study to include 185 clinical isolates of Salmonella sp., Shigella sp., Escherichia coli, and Campylobacter sp. as well as 25 rectal swab isolates of E. coli from clinically normal individuals. Cross-reactivity with B27+AS+ cells was initially assessed by the ability of these organisms to absorb the lymphocytotoxic activity of an anti-Klebsiella sp. serum for B27+AS+ lymphocytes and subsequently confirmed by raising antisera to those isolates which removed the cytotoxic activity of the anti-Klebsiella sp. serum. This survey has uncovered three Salmonella sp., two Shigella sp., one Campylobacter sp., and two E. coli isolates which were antigenically related to B27+AS+ lymphocytes. A B27-associated modifying factor (11) elaborated by these organisms shares antigenic determinants with a previously characterized Klebsiella sp. isolate (11) . The relevance of these findings to the pathogenesis of AS, particularly in the light of recent evidence supporting the specific role of procaryotic genetic material, will also be discussed.
MATERIALS AND METHODS
Patients. HLA-B27-positive and -negative patients were suffering from classical AS as defined by the New York and Rome criteria (4) . HLA-B27-positive and -negative healthy controls were staff members or blood donors with no history of joint disease. All patients and controls were tissue typed, using the twostage National Institutes of Health microlymphocytotoxicity test (18) (21) . To date, specific cytotoxic antibodies (9) to Klebsiella sp. K43 have been raised in 11 different rabbits from our outbred colony. Outbred guinea pigs (400 to 600 g) were also used to raise antisera against some of the Formalinkilled bacterial isolates.
In absorption studies, 0. (21) . The complement was used neat, but it was clearly in excess in the reaction since a 1:10 dilution was also effective in mediating lymphocytotoxicity (Table 1 ). In one series of experiments, 0.5 ml of complement was absorbed with about 5 x 109 Formalin-killed bacteria for 2 h at 4°C. This absorption treatment was repeated, and the twice-absorbed complement was filtered through a 0.2-,um-pore size membrane (Millipore Corp., Bedford, Mass.) and used in the lymphocytotoxicity assay.
The percentage of maximum 51Cr released was calculated as follows: percent 5tCr release = 100 x [(radioactivity released by antiserum -radioactivity released, in absence of antiserum)/(radioactivity released by Nonidet P-40-solubilized cells -radioactivity released in absence of antiserum)].
Assay for modifying factor activity. Peripheral blood lymphocytes or Epstein-Barr virus-transformed lymphoblastoid cell lines from HLA-B27-positive normal individuals (2) were used as targets in the cytotoxicity assay for modification by bacterial culture filtrates (11) . Briefly, 5 x 106 to 10 x 100 peripheral blood lymphocytes or lymphoblastoid cell lines were incubated overnight at 37°C in an atmosphere of 5% CO2 in air in 2 ml of RPMI 1640 (Flow Laboratories, Sydney, N.S.W., Australia) containing 20% human A serum supplemented with penicillin-streptomycin, with or without 100 ,ul of culture filtrates. The cells were then centrifuged at 800 x g for 10 min, resuspended in 1 ml (11) .
Bio-gel P-100 chromatography. Bio-Gel P-100 gel (100 to 200 mesh; Bio-Rad Laboratories, Richmond, Calif.) was equilibrated with phosphate-buffered saline and packed into a glass column (15 by 900 mm). The column was calibrated with the following protein standards (molecular weight in parentheses): bovine serum albumin (67,000), ovalbumin (43,000), pepsin (35,000), trypsinogen (24,000), and lysozyme (14,300). Twomilliliter samples of the culture filtrates were loaded onto the column and run at a flow rate of 3 ml/h at 4°C.) Fractions, 2.5 ml, were collected and assayed for modifying factor activity (23) .
Immunoadsorption experiments. Immunoadsorption columns were prepared as previously described (15) . In brief, 5 to 10 mg of 40% ammonium sulfate precipitates of serum from rabbits immunized with Klebsiella sp. K43 and Klebsiella sp. F77 were incorporated into 6 ml of polyacrylamide gel. Two-milliliter samples of concentrated culture filtrate were incubated with 3 ml of each immunoadsorbent for 16 h at 4°C. After the unadsorbed material was washed through the columns with 20 ml of phosphate-buffered saline, the adsorbed material was eluted with 10 ml of 0.1 M glycine-HCl buffer, pH 2.5, containing 0.9o NaCl, and the eluate was neutralized with 1 M Tris solution. The unadsorbed and adsorbed fractions were then concentrated to 2 ml on Amicon CF25 membrane cones and assayed for modifying factor activity.
RESULTS
Clinical isolates of certain enteric organisms remove the cytotoxic activity of an antiserum against a cross-reactive Kkebsiella sp. isolate. The data presented in Table 2 (Table 4) . Most of the adsorbed modifying factor (from the K43 column) was recovered by elution with 0.1 M glycine-HCI, pH 2.5 ( Table 4 ). The results suggest that the modifying factor elaborated by the four culture filtrates is antigenically related to Klebsiella sp. K43.
Bio-Gel P-100 chromatography of concentrated culture filtrates. HLA-B27-related modifying factor was fractionated on a Bio-Gel P-100 column. Samples (2 ml) of 80-fold-concentrated culture filtrates of S. newport BTS 52 and Shigella boydii BTS 20 were chromatographed on the Bio-Gel column and eluted with phosphatebuffered saline, and the fractions were tested for Bio-Gel P-100 chromatography of concentrated supernatant from S. newport BTS 52. Fractions, 2.5 ml, were collected and assayed for protein content (absorption at 280 nm) and for modifying factor activity as described in the text. The elution and activity profiles for Shigella boydii BTS 20 were virtually identical to those of S. newport BTS 52 (data not shown). Symbols: (----) absorption at 280 nm; (0) modifying factor activity. their ability to modify B27+AS-lymphocytes. The modifying activity of both organisms eluted as sharp peaks with identical elution profiles (Fig. 1) . The peaks corresponded to a molecular weight of 26,000 to 30,000 as previously reported by Sullivan et al. (23) . It is notable that the modifying activity peaks are well separated from the bulk of "contaminating" protein material.
E. coli isolated from the bowel flora of a clinically normal individual also cross-reacts with Kkebsiella sp. K43. In view of the presence in clinical isolates of cross-reactive enteric organisms, it was reasonable to wonder whether the bowel flora of clinically normal individuals would also include such an organism. E. coli was selected as a representative of normal bowel flora. Of 25 rectal swabs, only 1 specimen possessed a cross-reactive isolate of E. coli (Table  5 ). The individual (B27-AS-) harboring the cross-reactive E. coli isolate was further examined for carriage of this organism. Rectal The first question may be answered by the preliminary results (F. H. Cameron, P. J. Russell, J. Sullivan, and A. F. Geczy, Mol. Immunol., in press) of a recent study which suggest that an extrachromosomal element, possibly a plasmid, codes for the modifying factor produced by certain cross-reactive Klebsiella sp. isolates. It was shown that modifying factor production by a particular cross-reactive Klebsiella sp. isolate could be eliminated by "curing" the bacteria of plasmids with acridine orange. In a transconjugation experiment, an E. coli isolate, with no detectable plasmids, acquired the ability to produce modifying factor after mating with Klebsiella. sp. Although these early results provide only circumstantial evidence, they justify the hypothesis that modifying factor is produced by extrachromosomal elements such as plasmids. Such a mechanism could explain the production of modifying factor by bacteria across a broad spectrum of serologically unrelated organisms.
The role of infectious agents in the pathogenesis of AS is uncertain. Two suggestive findings bear further examination. First, it is well established that AS is related clinically and genetically to other seronegative inflammatory arthropathies such as Reiter's syndrome (25) . The latter is a form of reactive arthritis, strongly associated with the presence of HLA-B27 and apparently triggered by any one of three precipitating events: nonspecific urethritis, dysentery caused by certain shigellae or salmonellae, or unidentified factors (5) . Although 10 to 15% of patients with Reiter's syndrome ultimately develop AS, it is not known whether this is consequent upon the Reiter's syndrome or a second separate pathological process in an individual with a predisposition to both diseases (16) . Second, there are several reports of patients with AS and acute anterior uveitis having a higher incidence offecal carriage of Klebsiella sp. organisms than clinically normal individuals (6) (7) (8) . Although one group has disputed these findings (24) , they shed little light on the mechanism of disease triggering, for it is not clear whether any of these organisms is cross-reactive with the HLA-B27-positive cells from patients with AS or whether any of them generates B27-associated modifying factor.
INFECT. IMMUN.
The possible involvement of microbial organisms or their products in AS may be less conspicuous; that is, the environmental agent may simply act as a focus or a source of genetic material, such as plasmids, which may then interact with HLA-B27-positive cells, as we suggested previously (22) . In AS an HLA-associated structure, such as the antigenic determinant shared by several enteric bacteria, may mediate or facilitate the attachment to mucosal surfaces of certain enteric bacteria. This attachment, which is mediated by species-specific microbial adhesins to complementary receptors on the host tissue, is probably essential to the infectious process (3, 17, 20) .
These examples aside, there is no clinical evidence to implicate enteric or other infection in the etiology of AS. However, infections cannot be exonerated: the individual's exposure may precede the onset of rheumatic symptoms by many years and, more importantly, the infectious agent may be otherwise nonpathogenic. If the B27-associated cell-surface modification is important in the pathogenesis of AS, the results of the present study provide an important extension to the concept of a role for bacteria. This study demonstrates that a range of bacteria, including an E. coli isolate from normal bowel flora, can elaborate a modifying factor identical to that produced by the Klebsiella sp. organisms previously studied: this E. coli isolate has been shown to persist for a period of at least 2 months. In the light of this observation, it would be important to study the persistence of crossreactive enteric organisms in the bowel flora of genetically susceptible individuals.
A conclusive statement on the presence, in clinical isolates of enteric organisms, of genes coding for the B27-associated antigenic complex can only be made if hybridization studies can detect such genes. Furthermore, DNA hybridization studies may also enable us to investigate the possibility that plasmid DNA is present in the genome of the cells of patients with AS; these studies are currently in progress.
